[HTML][HTML] Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma
CJ Heuck, P Qu, F Van Rhee, S Waheed, SZ Usmani… - Leukemia, 2014 - nature.com
CJ Heuck, P Qu, F Van Rhee, S Waheed, SZ Usmani, J Epstein, Q Zhang, R Edmondson…
Leukemia, 2014•nature.com1 Schmid C, Labopin M, Nagler A, Bornhauser M, Finke J, Fassas A et al. Donor lymphocyte
infusion in the treatment of first hematological relapse after allogeneic stem-cell
transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis
and comparison with other strategies by the EBMT Acute Leukemia Working Party. J Clin
Oncol 2007; 25: 4938-4945.
infusion in the treatment of first hematological relapse after allogeneic stem-cell
transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis
and comparison with other strategies by the EBMT Acute Leukemia Working Party. J Clin
Oncol 2007; 25: 4938-4945.
1 Schmid C, Labopin M, Nagler A, Bornhauser M, Finke J, Fassas A et al. Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party. J Clin Oncol 2007; 25: 4938-4945.
nature.com